Medtronic Q3 EPS Beats by 3 Cents, Revenues Up 1.35% but Shares Drop 3.5%
Medtronic reported fiscal third-quarter EPS of $1.36, beating consensus by $0.03 and delivering revenues 1.35% above estimates. Despite results, shares fell 3.5% premarket as the company warned of tariff impacts on upcoming quarters.
1. Third-Quarter Earnings Beat Expectations
Medtronic delivered fiscal third-quarter EPS of $1.36, surpassing estimates by $0.03, while revenues came in 1.35% above consensus. This marks the second consecutive quarter of top- and bottom-line outperformance for the medical devices leader.
2. Shares Slide Despite Strong Metrics
In pre-market trading, Medtronic shares fell 3.5% despite the earnings beat and revenue upside. Market reaction suggests investors are weighing near-term headwinds more heavily than the company’s latest performance.
3. Tariff Headwinds Forecast
Management flagged potential tariff impacts on production costs and supply chains in upcoming quarters. The announcement of these headwinds has introduced uncertainty around future margins and cost structures.